A PHASE 1, SINGLE-ASCENDING DOSE, MULTIPLE-ASCENDING DOSE, AND MULTI DOSE SAFETY, TOLERABILITY, PHARAMCOKINETICS, AND PHARACODYNAMICS STUDY OF SUBCUTANEOUSLY ADMINISTERED ALN-AS1 IN PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA (AIP)

    Project: Other project

    Project Details

    StatusFinished
    Effective start/end date1/22/16 → 1/21/19